Key result
Sphenostylis stenocarpa seed milk lowers the atherogenic index in hyperlipidemic rats in a dose-dependent manner.
Why the study?
Hyperlipidaemia is a major modifiable risk factor for atherosclerotic cardiovascular diseases, and the hypolipidaemic potential of milk extracted from the underutilized legume seed Sphenostylis stenocarpa needed investigation as a dietary-based intervention.
Does Sphenostylis stenocarpa seed milk reduce the plasma atherogenic index in albino rats with high-fat diet-induced hyperlipidaemia?
Does Sphenostylis stenocarpa seed milk reduce the plasma atherogenic index in albino rats with high-fat diet-induced hyperlipidaemia?
Answers are grounded in this paper and cite their sources.
In a preclinical rat model of diet-induced hyperlipidaemia, Sphenostylis stenocarpa seed milk significantly reduced the plasma atherogenic index, suggesting potential as a functional dietary adjunct for lipid management.
Background: Hyperlipidaemia is a major modifiable risk factor for atherosclerotic cardiovascular diseases, including coronary artery disease, cerebrovascular disorders, and peripheral arterial disease. It is commonly associated with unhealthy dietary habits, physical inactivity, obesity, DM, endocrine disorders, and hepatic or renal dysfunctions. While pharmacological management remains central, dietary-based interventions using functional foods. Methodology: The hypolipidaemic potential of milk extracted from Sphenostylis stenocarpa (Hochst. Ex A. Rich) Harms, some underutilized legume seed rich in bioactive constituents. Hyperlipidaemia was experimentally induced in albino rats using a high-fat diet, after which the animals were administered with graded concentrations of Sphenostylis stenocarpa seed milk. Results: Lipid-related indices, particularly the plasma atherogenic index (AIP), were assessed to determine cardiovascular risk. Administration of the seed milk resulted in a significant (p < 0.05) reduction in AIP compared with untreated hyperlipidemic controls, with dose- and time-dependent. Discussion: The observed hypolipidaemic activity was attributable to the high phytochemical and dietary fiber content of the seed milk, which facilitated the clearance of cholesterol from the systemic circulation. These findings suggest that Sphenostylis stenocarpa seed milk possesses promising cardioprotective properties. Conclusion: The seed oil of African yam bean possesses anti-hypolipidaemic potential; therefore, Sphenostylis stenocarpa may serve as a functional dietary adjunct for the prevention and management of hyperlipidaemia. This work thereby recommends that African yam bean be mass-produced and its consumption encouraged among the populace since it was found to be a functional food.
No takes yet. Share an insight, caveat, or question.
Olisa et al. (2026) studied Hyperlipidaemia. Sphenostylis stenocarpa (African yam bean) seed milk vs. Untreated hyperlipidemic controls was evaluated on Plasma atherogenic index (AIP) (p=< 0.05). Sphenostylis stenocarpa seed milk reduced the plasma atherogenic index in hyperlipidemic rats compared with untreated controls in a dose- and time-dependent manner.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: